|
Issue |
Title |
|
No 2 (2025) |
Pityriasis versicolor – mechanism of development and approaches to therapy |
Abstract
PDF (Rus)
|
E. E. Zhiltsova, S. A. Politov, I. V. Kanina, N. A. Golovina, O. V. Bakovetskaya, S. V. Mikheikina |
|
No 2 (2025) |
Psoriasis and cancer: experience of using IL-17 inhibitor in a patient with severe psoriasis and a history of prostate cancer |
Abstract
PDF (Rus)
|
E. V. Svechnikova, S. Е. Zhufina |
|
No 2 (2025) |
IL-23 inhibitors in psoriasis treatment: Current perspectives and emerging horizons |
Abstract
PDF (Rus)
|
О. V. Zhukova, S. I. Artemyeva |
|
No 2 (2025) |
Psoriasis and its impact on liver health: What a dermatologist needs to know |
Abstract
PDF (Rus)
|
E. V. Denisova, K. V. Katkova, K. T. Plieva, O. V. Zhukova, I. M. Korsunskaya |
|
No 2 (2025) |
Clinical and anamnestic features of dyshidrotic eczema: A cross-sectional study |
Abstract
PDF (Rus)
|
A. S. Shachnev, O. V. Zhukova, E. I. Kasikhina |
|
No 2 (2025) |
Psoriasis – complex mechanisms of pathogenesis and comorbidity: Do we know everything? |
Abstract
PDF (Rus)
|
A. A. Arsenyeva |
|
No 2 (2025) |
External therapy of scalp psoriasis: From relieving exacerbations to persistent remission |
Abstract
PDF (Rus)
|
M. M. Tlish, T. G. Kuznetsova, M. E. Shavilova, F. A. Psavok |
|
No 2 (2025) |
Biomarkers of vascular well-being as risk factors for rosacea in perimenopausal women |
Abstract
PDF (Rus)
|
Ju. S. Kovaleva, M. G. Nikolaeva, S. V. Reshetova |
|
No 2 (2025) |
Secreted matrix metalloproteinases: Study of the expression profiles in the skin affected by scleroderma |
Abstract
PDF (Rus)
|
A. V. Mezentsev, Z. A. Nevozinskaya, V. V. Sobolev, A. G. Soboleva, N. N. Potekaev, I. M. Korsunskaya |
|
No 2 (2025) |
Study of skin microbiota in patients with chronic lichenoid parapsoriasis |
Abstract
PDF (Rus)
|
E. A. Sultanova, E. V. Dvoriankova, Z. R. Khismatullina, K. M. Koreshkova, M. M. Tuigunov |
|
No 2 (2025) |
Targeted therapy for psoriasis: Pathogenetic aspects and effectiveness |
Abstract
PDF (Rus)
|
E. E. Zhiltsova, R. R. Shilin, D. B. Sonin, O. V. Bakovetskaya, A. E. Filchkova |
|
No 2 (2025) |
Clinical, epidemiological and laboratory features of insect allergy in cutaneous mastocytosis |
Abstract
PDF (Rus)
|
E. I. Kasikhina, M. N. Ostretsova, A. Ya. Nada |
|
No 2 (2025) |
Drug effects on skin: Xerosis as a side effect |
Abstract
PDF (Rus)
|
L. R. Sakaniya, I. V. Olenich, I. M. Korsunskaya |
|
No 2 (2025) |
Recognizing secondary infection in patients with atopic dermatitis: Head & neck atopic dermatitis |
Abstract
PDF (Rus)
|
O. B. Tamrazova, A. V. Tamrazova, G. A. Novik, M. V. Zhdanova, A. S. Stadnikova, A. G. Sukhotina |
|
No 14 (2024) |
Dynamics of the level of interleukin 31 and 33, cortisol and filaggrin in the blood serum of pregnant women with atopic dermatitis during treatment with a combination of an emollient and a topical antipruritic agent |
Abstract
PDF (Rus)
|
E. A. Orlova, Yu. A. Kandrashkina, O. A. Levashova, E. M. Kostina, A. F. Shtakh |
|
No 14 (2024) |
The possibilities of improving the effectiveness of acne therapy |
Abstract
PDF (Rus)
|
R. M. Zagrtdinova, R. N. Zagrtdinova, E. Sh. Mustafayeva |
|
No 14 (2024) |
Review of modern melasma treatment methods |
Abstract
PDF (Rus)
|
N. Yu. Bychkova, V. E. Lemytskaya, Yu. A. Sokolovskaya, O. V. Zhukova, E. I. Kasikhina |
|
No 14 (2024) |
Algorithms for topical therapy of mycoses at the daily appointment of a dermatologist |
Abstract
PDF (Rus)
|
L. V. Silina |
|
No 14 (2024) |
Quality of life of patients with dyshidrotic eczema: a cross-sectional study |
Abstract
PDF (Rus)
|
A. S. Shachnev, O. V. Zhukova, E. I. Kasikhina |
|
No 14 (2024) |
Immunologic markers for vitiligo |
Abstract
PDF (Rus)
|
V. V. Petunina |
|
No 14 (2024) |
Topical psoriasis therapy: An innovative classic |
Abstract
PDF (Rus)
|
L. S. Kruglova, E. A. Shatokhina |
|
No 14 (2024) |
Mastocytoma and juvenile xanthogranuloma in children |
Abstract
PDF (Rus)
|
N. N. Potekaev, E. I. Kasikhina, М. N. Ostretsova, V. N. Grebenyuk, M. A. Kochetkov, O. R. Katunina, K. I. Buzina |
|
No 14 (2024) |
Comparative analysis of Health-Related Quality of Life, anxiety and depression in patients with alopecia areata, atopic dermatitis and with association of these diseases |
Abstract
PDF (Rus)
|
G. P. Tereshchenko, A. G. Gadzhigoroeva, Yu. Yu. Romanova, N. N. Potekaev |
|
No 14 (2024) |
Hidradenitis suppurativa: latest insights on the etiology, pathogenesis and features of therapy |
Abstract
PDF (Rus)
|
E. V. Svechnikova, S. Е. Zhufina |
|
No 14 (2024) |
Psychodermatological disorders as an interdisciplinary problem: diagnostic features based on the example of our own clinical observations |
Abstract
PDF (Rus)
|
M. M. Tlish, M. E. Shavilova, N. A. Boyko, G. V. Romanova |
|
No 14 (2024) |
Comparative analysis of selected gene expression profiles in peripheral blood mononuclear cells in patients with rosacea and healthy volunteers |
Abstract
PDF (Rus)
|
N. G. Tserikidze, A. G. Soboleva, V. V. Sobolev, L. R. Sakaniya, N. N. Potekaev, I. M. Korsunskaya |
|
No 14 (2024) |
Netakimab in the treatment of psoriatic erythroderma |
Abstract
PDF (Rus)
|
G. N. Tarasenko, I. V. Patronov |
|
No 14 (2024) |
New topical combinations in acne therapy |
Abstract
PDF (Rus)
|
О. A. Katkhanova |
|
No 14 (2024) |
Biological gene therapy for psoriasis: more than just skin clearance |
Abstract
PDF (Rus)
|
О. V. Zhukova, S. I. Artemyeva |
|
No 2 (2024) |
Peri-wound skin lesions of allergic nature |
Abstract
PDF (Rus)
|
E. V. Dvoriankova, G. A. Shevchenko |
|
No 2 (2024) |
Non-alcoholic fatty liver disease and psoriasis: mechanisms of comorbidity and approaches to therapy |
Abstract
PDF (Rus)
|
M. A. Livzan, O. V. Gaus, I. N. Ekimov |
|
No 2 (2024) |
Cheilitis: causes, therapy and prevention |
Abstract
PDF (Rus)
|
L. R. Sakaniya, A. V. Pavlova, I. M. Korsunskaya |
|
No 2 (2024) |
Advantages of IL-17 inhibitor, ixekizumab, in the treatment of severe psoriasis |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. I. Artemyeva |
|
No 2 (2024) |
Therapeutic potential of the treatment and control of severe recurrent atopic dermatitis |
Abstract
PDF (Rus)
|
O. B. Tamrazova, A. S. Stadnikova, G. A. Novik, A. G. Sukhotina, A. S. Vorobeva, G. E. Bagramova, A. A. Bezukladnova |
|
No 2 (2024) |
Modern realities of correction of skin barrier disorders in various diseases |
Abstract
PDF (Rus)
|
O. V. Zhukova, G. P. Tereshchenko, E. I. Kasikhina, M. N. Ostretsova, A. A.M. Nemer |
|
No 2 (2024) |
Studying the role of cortisol in the pathogenesis of atopic dermatitis during pregnancy |
Abstract
PDF (Rus)
|
Ju. A. Kandrashkina, E. A. Orlova, E. M. Kostina |
|
No 2 (2024) |
JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice |
Abstract
PDF (Rus)
|
N. N. Potekaev, G. P. Tereshchenko, A. G. Gadzhigoroeva |
|
No 2 (2024) |
The problem of treating acne and rosacea in women of reproductive age |
Abstract
PDF (Rus)
|
D. R. Mildzikhova, L. R. Sakaniya, N. G. Tserikidze, I. M. Korsunskaya |
|
No 2 (2024) |
Methods of rosacea treatment to achieve stable remission in a megalopolis |
Abstract
PDF (Rus)
|
A. D. Vilochkina, V. S. Lindover, E. A. Galukhina, Ya. O. Murtazina, U. A. Garanova, A. R. Chekanova, K. P. Raevskiy |
|
No 2 (2024) |
Post-inflammatory hyperpigmentation post-acne: possibilities of topical therapy |
Abstract
PDF (Rus)
|
O. V. Zhukova, M. N. Ostretsova, A. V. Kostetskaia, A. L. Savastenko, S. S. Ismatullaeva, Yu. A. Sokolovskaya |
|
No 2 (2024) |
Hand eczema: a common diagnosis in everyday practice |
Abstract
PDF (Rus)
|
Z. A. Nevozinskaya, L. R. Sakaniya, I. M. Korsunskaya |
|
No 2 (2024) |
Experience with interleukin-23 inhibitor guselkumab using in patients with severe psoriasis and the impact of the disease on the psycho-emotional background |
Abstract
PDF (Rus)
|
E. V. Svechnikova, S. E. Zhufina |
|
No 2 (2024) |
Modern approaches to the treatment of superficial pyoderma in the practice of a dermatologist |
Abstract
PDF (Rus)
|
O. Yu. Olisova, E. V. Grekova |
|
No 2 (2024) |
Therapy of moderate-to-severe plaque psoriasis |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. I. Artemyeva |
|
No 2 (2024) |
Complex therapy of contact dermatitis: from theory to practice |
Abstract
PDF (Rus)
|
L. V. Silina |
|
No 14 (2023) |
The role of alarmins in the pathogenesis of psoriasis |
Abstract
PDF (Rus)
|
A. V. Mezentsev, E. V. Denisova, V. V. Sobolev, I. M. Korsunskaya |
|
No 14 (2023) |
Alterations in IL-17 expression in pediatric patients with psoriatic arthritis |
Abstract
PDF (Rus)
|
S. N. Chebysheva, V. V. Sobolev, N. A. Geppe, A. G. Soboleva, I. M. Korsunskaya |
|
No 14 (2023) |
Clinical case of the sepsis development in a patient with bullous pemphigoid |
Abstract
PDF (Rus)
|
M. N. Bulanov, A. A. Kazakov, I. V. Khamaganova, P. O. Kazakova, S. V. Potapova |
|
No 14 (2023) |
Efficacy and safety assessment of netakimab in scalp psoriasis |
Abstract
PDF (Rus)
|
M. I. Kurdina, N. G. Kolenko |
|
No 14 (2023) |
The use of a combination drug with adapalene/metronidazole for acne |
Abstract
PDF (Rus)
|
E. V. Matushevskaya, E. V. Vladimirova, Yu. I. Matushevskaya |
|
No 14 (2023) |
The selection of the initial drug in the treatment of severe psoriasis |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. I. Artemyeva |
|
No 14 (2023) |
Contact dermatitis: etiopathogenetic aspects of the formation of the clinical picture and the rational choice of external therapy |
Abstract
PDF (Rus)
|
M. M. Tlish, M. E. Shavilova |
|
No 14 (2023) |
Skin microbiome in patients with acne |
Abstract
PDF (Rus)
|
E. V. Dvoriankova, M. I. Denieva, Z. R. Khismatullina |
|
No 14 (2023) |
The role of dermatocosmetics in the management of rosacea |
Abstract
PDF (Rus)
|
N. G. Tserikidze, L. R. Sakaniya, I. V. Olenich, I. M. Korsunskaya |
|
No 2 (2023) |
Actual view on skin scarring and clinical experience of conservative treatment of keloids |
Abstract
PDF (Rus)
|
O. V. Zhukova, O. V. Porshina, M. N. Ostretsova, V. E. Lemytskaya |
|
No 2 (2023) |
Microbic eczema – trigger points of influence |
Abstract
PDF (Rus)
|
J. S. Kovaleva, N. G. Komkina |
|
No 2 (2023) |
The feasibility of the use of monoclonal antibodies to interleukin 23 in the therapy of severe psoriasis with the eluding effect of genetically engineered biological drugs |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. I. Artemyeva, A.A.-H. M. Al-Hawatmi |
|
No 2 (2023) |
Photosensitive dermatoses in paediatric practice |
Abstract
PDF (Rus)
|
O. B. Tamrazova, A. S. Stadnikova, G. A. Novik, G. E. Bagramova |
|
No 2 (2023) |
Adult female acne: relevance and possible solutions |
Abstract
PDF (Rus)
|
O. V. Zhukova, E. I. Kasikhina, M. N. Ostretsova, S. S. Ismatullaeva |
|
No 2 (2023) |
Clinical case: switching from basic therapy with methotrexate to therapy with netakimab, an IL-17 inhibitor, in a patient with severe psoriasis |
Abstract
PDF (Rus)
|
E. V. Svechnikova, S. E. Zhufina, M. A. Morzhanaeva |
|
No 2 (2023) |
Acne resistance issues: solutions |
Abstract
PDF (Rus)
|
J. S. Kovaleva, O. A. Kokina, T. N. Shepileva |
|
No 2 (2023) |
A potential inflammatory role of Toll-like receptor-2 in psoriatic arthritis |
Abstract
PDF (Rus)
|
V. V. Sobolev, S. N. Chebysheva, E. V. Denisova, S. I. Artemуeva, N. A. Geppe, A. G. Soboleva, I. M. Korsunskaya |
|
No 13 (2022) |
Comparative evaluation of therapy results in mild acne |
Abstract
PDF (Rus)
|
I. M. Khismatulina, E. V. Faizullina, E. S. Gusarova, R. R. Nabieva |
|
No 13 (2022) |
Coronavirus infection and psoriasis: relationship and consequences |
Abstract
PDF (Rus)
|
K. V. Katkova, E. V. Denisova, A. G. Soboleva, E. A. Pechatnikova, O. V. Zhukova, V. V. Sobolev, I. M. Korsunskaya |
|
No 13 (2022) |
Psychiatric comorbidity and psycho-emotional status of patients with acne |
Abstract
PDF (Rus)
|
E. V. Dvoriankova, N. A. Shevchenko, O. V. Zhukova |
|
No 13 (2022) |
Issues of therapy for post-acne post-inflammatory hyperpigmentation |
Abstract
PDF (Rus)
|
L. S. Kruglova, N. V. Gryazeva |
|
No 13 (2022) |
Netakimab in the therapy of psoriatic onychodystrophy |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. I. Artemyeva, A. Al-Hawatmi, E. A. Pechatnikova |
|
No 13 (2022) |
TNF-α gene expression in immune cells of patients with psoriasis and psoriatic arthritis |
Abstract
PDF (Rus)
|
V. V. Sobolev, S. N. Chebysheva, N. A. Geppe, K. V. Katkova, A. G. Soboleva, I. M. Korsunskaya |
|
No 3 (2022) |
Exposome factors in the acne pathogenesis |
Abstract
PDF (Rus)
|
I. O. Smirnova, A. O. Zhelonkina, A. R. Zhelonkin, Y. G. Petunova, N. V. Shin, A. Y. Bessalova, E. A. Kulikova, N. E. Novikova, P. D. Ptashnikova |
|
No 3 (2022) |
Current advances in biological therapy of psoriasis: efficacy of guselkumab in real clinical practice |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. I. Artemyeva |
|
No 3 (2022) |
Management of the post-procedural period in aesthetic medicine – prevention of complications and reduction of the rehabilitation period |
Abstract
PDF (Rus)
|
M. N. Ostretsova, A. Korenevska, E. I. Kasikhina, S. S. Ismatullaeva |
|
No 3 (2022) |
The efficacy and safety study of the combined use of platelet-rich plasma and fractional radiofrequency ablation in the treatment of post-acne scars |
Abstract
PDF (Rus)
|
V. A. Blyumina, M. N. Ostretsova, N. A. Jardali |
|
No 3 (2022) |
Hand eczema: possible risks and choice of therapy |
Abstract
PDF (Rus)
|
L. R. Sakaniya, O. Yu. Smolkina, I. M. Korsunskaya |
|
No 3 (2022) |
Nail psoriasis: dynamics of the clinical course during anti-IL-17 therapy |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. I. Artemyeva, A.A.-H.M. Al-Hawatmi |
|
No 3 (2022) |
Steroid-refractory hand eczema: treatment experience |
Abstract
PDF (Rus)
|
A. V. Kostetskaia, E. I. Kasikhina, M. N. Ostretsova, A. L. Savastenko, N. N. Potekaev |
|
No 3 (2022) |
Diapason of concomitant diseases in children with psoriasis |
Abstract
PDF (Rus)
|
A. A. Valiev, K. N. Khaitov, Sh. T. Turdieva |
|
No 3 (2022) |
The role of vitamin D in the prevention of pathology associated with psoriasis and metabolic syndrome |
Abstract
PDF (Rus)
|
E. V. Matushevskaya, I. A. Komissarenko, E. V. Vladimirova, Yu. I. Matushevskaya, Yu. V. Konev, S. V. Levchenko |
|
No 3 (2022) |
Infectious complications of atopic dermatitis |
Abstract
PDF (Rus)
|
E. V. Dvoriankova, M. I. Denieva, G. А. Shevchenko |
|
No 8 (2021) |
Skin bacterial infections – always a topical problem |
Abstract
PDF (Rus)
|
A. L. Piruzyan, Z. A. Niewozinska, I. M. Korsunskaya |
|
No 8 (2021) |
Fluticasone propionate for external use: pharmacological properties and clinical effectiveness |
Abstract
PDF (Rus)
|
E. V. Dvoriankova |
|
No 8 (2021) |
Solitary mastocytoma in children: a retrospective analysis of the clinical course and timing of regression |
Abstract
PDF (Rus)
|
E. I. Kasikhina, M. N. Ostretsova, G. P. Tereshchenko |
|
No 8 (2021) |
Experience of applying a multi-component gel based on troxerutin, heparin sodium and dexpanthenol in the rehabilitation of patients after cosmetic procedures |
Abstract
PDF (Rus)
|
M. N. Ostretsova, A. Korenevskaya, E. I. Kasikhina, O. V. Zhukova |
|
No 8 (2021) |
Combined pathogenetic therapy of allergic dermatoses in children |
Abstract
PDF (Rus)
|
J. S. Kovaleva, N. K. Zyablitskaya, M. V. Orobei, N. K. Bishevskaya |
|
No 8 (2021) |
New possibilities of systemic therapy of plaque psoriasis with the IL23p19 inhibitor risankizumab |
Abstract
PDF (Rus)
|
O. V. Zhukova, E. I. Kasikhina, M. N. Ostretsova, N. N. Potekaev |
|
No 8 (2021) |
Topical psoriasis therapy. Review of clinical cases |
Abstract
PDF (Rus)
|
E. V. Matushevskaya, E. V. Vladimirova, Yu. I. Matushevskaya, E. A. Averbukh, A. Yu. Shatalova |
|
No 8 (2021) |
Management of patients at high risk of developing skin melanoma: organizational and clinical aspects |
Abstract
PDF (Rus)
|
A. V. Michenko, O. V. Zhukova, M. N. Ostretsova, O. L. Novozhilova |
|
No 12 (2020) |
Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies |
Abstract
PDF (Rus)
|
N. N. Potekaev, O. V. Zhukova, S. I. Artemyeva |
|
No 12 (2020) |
Therapeutic possibilities of topical corticosteroids in modern clinical practice |
Abstract
PDF (Rus)
|
T. A. Belousova, M. V. Kail |
|
No 12 (2020) |
The patient's path to AD: a study of patients adherence to therapy |
Abstract
PDF (Rus)
|
L. S. Kruglova, N. V. Griazeva |
|
No 12 (2020) |
The efficacy and safety of local therapy of atopic dermatitis in infants and school-age children |
Abstract
PDF (Rus)
|
O. I. Sidorovich, A. A. Tsyvkina, G. D. Abdullaeva |
|
No 12 (2020) |
Diffuse hair loss in women: causes and therapeutic approach |
Abstract
PDF (Rus)
|
O. O. Melnichenko, A. L. Piruzyan, I. M. Korsunskaya |
|
No 12 (2020) |
Successful use of Netakimab in the treatment of psoriasis accompanied by the psoriatic onychodystrophy |
Abstract
PDF (Rus)
|
N. N. Potekaev, O. V. Zhukova, S. I. Artemyeva |
|
No 12 (2020) |
Experience in managing psoriasis patients receiving targeted therapy during the COVID-19 pandemic |
Abstract
PDF (Rus)
|
N. N. Potekaev, O. V. Zhukova, S. I. Artemyeva, M. N. Ostretsova |
|
No 12 (2020) |
1% ivermectin in combination therapy regimens for rosacea |
Abstract
PDF (Rus)
|
E. A. Khlystova, A. L. Savastenko |
|
No 12 (2020) |
Foot mycosis: how to help active patients |
Abstract
PDF (Rus)
|
L. R. Sakaniya, I. M. Korsunskaya |
|
1 - 95 of 95 Items |
|